Menu

Gynecomastia: When a Change in Chest Tissue Needs a Workup
Dr. Michael Zimmer

Dr. Michael A. Zimmer

Gynecomastia: When a Change in Chest Tissue Needs a Workup

Medically reviewed by Michael A. Zimmer, MD, MACPBoard-Certified Internal Medicine, Medical Director
Post Summary

Breast tissue development in men deserves evaluation — especially when it is new, one-sided, tender, or appears after starting a new medication. Here is what is usually benign, what is not, and the medications most commonly responsible.

Gynecomastia: When Male Chest Tissue Needs a Workup

Most men will notice tenderness or tissue behind the nipple at some point — often in early puberty, sometimes in middle or older age. Much of this is benign and resolves on its own. But gynecomastia can also be the first clue to a hormonal imbalance, a medication side effect, or, rarely, something more serious. Knowing when to watch and when to work it up is the goal of this article.

At Zimmer Medical Group in St. Petersburg, Dr. Michael A. Zimmer evaluates gynecomastia as part of comprehensive men's health care, including hormones, medications, and overall health.

Normal vs Pathologic

There are several physiologic variants that are considered normal.

  • Infancy: Transient, driven by maternal hormones. Resolves in weeks.
  • Puberty: 50-60% of teen boys have some breast tenderness or tissue. Usually resolves within 1-2 years.
  • Older age: As testosterone declines and relative estrogen rises, breast tissue can increase. Abdominal fat (which produces estrogen from testosterone) contributes.

Pathologic gynecomastia is glandular tissue driven by an imbalance between estrogen and androgen action — or by a medication that interferes with it. MedlinePlus offers a good overview, and the Urology Care Foundation has an in-depth page.

Gynecomastia vs Pseudogynecomastia

On exam, we pinch the tissue between thumb and forefinger. Gynecomastia feels like a firm, rubbery disc centered beneath the areola. Pseudogynecomastia — fat only, no glandular tissue — feels soft and fatty throughout. This distinction matters because pseudogynecomastia responds to weight loss, while true gynecomastia does not.

When to Work It Up

Not every case needs labs and imaging. We escalate when:

  • New onset in an adult man,
  • Unilateral, especially if firm or eccentric,
  • Rapidly progressing,
  • Tender out of proportion to size,
  • Accompanied by testicular changes, loss of libido, sexual dysfunction, or systemic symptoms.

The Standard Lab Panel

  • Total testosterone, ideally morning and fasting,
  • LH and FSH,
  • SHBG, to calculate free testosterone,
  • Estradiol,
  • Prolactin,
  • TSH — hyperthyroidism is an underrecognized cause,
  • hCG, if testicular tumor is suspected,
  • Liver and kidney function.

Testicular exam is always part of the workup; scrotal ultrasound follows if any asymmetry, mass, or elevated hCG is found.

Common Pathologic Causes

  • Primary hypogonadism (testicular failure) — worth learning about in more depth if testosterone is low; our guide on when to test and treat low testosterone covers this.
  • Hyperthyroidism.
  • Liver cirrhosis and significant renal disease.
  • Medications: spironolactone, finasteride, cimetidine, ketoconazole, some chemotherapy agents, opioids, and anabolic steroids (including over-the-counter "testosterone boosters" that are actually estrogenic).
  • Substances: high-dose soy products, and marijuana (mixed data).
  • Refeeding after significant weight loss or illness.

Always ask directly — and honestly — about supplements, pro-hormones, and performance products. Many men do not volunteer these, and they are common drivers.

Treating the Underlying Cause

Most cases resolve or stabilize when the cause is addressed: stop or switch a medication, treat BPH differently if finasteride is the trigger, correct hypogonadism, manage thyroid disease, or optimize weight and liver health.

There is an important time window. In the first 12 months, gynecomastia is often inflammatory and reversible. After 12-18 months, tissue becomes fibrotic, and medical therapy becomes less effective.

Medical and Surgical Options

  • Selective estrogen receptor modulators (tamoxifen, raloxifene) have modest evidence in the earlier phase.
  • Aromatase inhibitors are generally underwhelming.
  • Surgery — liposuction for fatty-predominant cases, glandular excision for fibrotic disease — is definitive when persistent.

Red Flags for Male Breast Cancer

Male breast cancer accounts for about 1% of all breast cancers, but it exists, and it tends to present later in men because the possibility is overlooked. Red flags include:

  • Unilateral firm or hard mass, off-center from the nipple,
  • Skin dimpling or retraction,
  • Bloody or spontaneous nipple discharge,
  • Rapid growth,
  • Axillary lymphadenopathy.

Any of these warrant imaging (mammogram and/or ultrasound) and often biopsy. Your family history matters here too — BRCA mutations substantially increase male breast cancer risk.

Where This Fits in Men's Health

Think of gynecomastia as one piece of a broader men's health review, alongside hormones, cardiovascular risk, and cancer screening. Our men's health checklist walks through what should be covered at a typical visit.

What Happens After the Workup

The labs come back, the exam is done, and the question becomes what to actually do. In practice the answer falls into one of three paths, and knowing which one you are on takes most of the anxiety out of it.

If a medication or supplement is the cause

This is the most common finding and the most fixable. Spironolactone is a frequent culprit, and so is finasteride, along with cimetidine, ketoconazole, some antipsychotics, and anabolic steroids or over-the-counter products marketed as testosterone boosters. Where a substitute exists, we switch, and where the drug is genuinely necessary we weigh the trade-off honestly. Improvement takes months, not weeks, and the earlier the change is made the more likely the tissue regresses rather than scars. This is why I push people to come in when they first notice a change rather than after a year of hoping.

If testosterone is low or weight is driving it

When the panel shows low testosterone, we treat the deficiency and follow the chest, but with a caveat worth saying plainly: replacement therapy such as testosterone cypionate can be converted to estrogen in the body and sometimes makes gynecomastia worse before it makes it better, so we monitor rather than assume. Where obesity is a major factor, weight loss reduces the fatty component and lowers the estrogen produced in fat tissue, but it will not dissolve true glandular tissue. Fatty liver disease and alcohol-related liver injury both shift the hormonal balance and are worth addressing in their own right. The Endocrine Society's patient page on gynecomastia covers this territory well.

If nothing is found and it simply persists

Plenty of men come through a complete workup with normal labs and no offending drug. In that situation the decision is about bother, not danger. Within the first year, a trial of tamoxifen has modest evidence for reducing tenderness and size. Beyond eighteen months the tissue is usually fibrotic and surgery is the reliable option. What we do not do is stop paying attention: any new firm off-center mass, skin dimpling, or nipple discharge gets imaged, because male breast cancer is uncommon but real and tends to present late. MedlinePlus on male breast cancer lists the warning signs worth knowing.

Get It Evaluated

If you have noticed new or changing chest tissue, do not guess. Schedule a visit with Dr. Zimmer. An exam, a focused lab panel, and a careful history will tell us whether this is normal variation or something worth treating.

Frequently Asked Questions

It depends on what the tissue actually is. Pseudogynecomastia, which is fat without glandular tissue, responds well to weight loss. True gynecomastia is a firm rubbery disc of glandular tissue under the nipple, and it does not dissolve with weight loss, although losing weight does reduce the surrounding fat and the estrogen that fat tissue produces. An exam distinguishes the two in about a minute.
Spironolactone is among the most frequent, along with finasteride, cimetidine, ketoconazole, certain antipsychotics, some HIV and chemotherapy drugs, opioids, and anabolic steroids. Over-the-counter testosterone boosters and pro-hormones belong on that list too and often go unmentioned because people do not think of supplements as drugs. Bring every bottle to the visit, including anything bought online or at a gym.
Months rather than weeks, and the timing of the change matters. In roughly the first year the tissue is still inflammatory and reversible, so removing the cause often leads to real regression. After about twelve to eighteen months the tissue becomes fibrotic, and at that point medication rarely helps much and surgery becomes the dependable option. That window is the reason to get evaluated early.
Ordinary gynecomastia is symmetric under the nipple, rubbery, and often tender. The features that concern me are a hard or firm mass off to the side of the nipple rather than centered under it, usually on one side only, along with skin dimpling or retraction, bloody or spontaneous nipple discharge, rapid growth, or a swollen lymph node in the armpit. Any of those means imaging, not watchful waiting.